Cigna Contract For Rebif Has Three-Year Price Inflation “Hedge”
Cigna views the price provision in its latest Rebif contract as a model for its other specialty drug contracts, Cigna VP Thom Stambaugh tells National Business Group on Health.
You may also be interested in...
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.
Effectiveness can be evaluated more quickly because researchers won’t have to wait for the second dose, company executive notes during briefing on the launch of the Phase III study.